U.S. stocks are little changed early Wednesday, one day after a strong rally sent to the S&P 500 to a new record close.
10 things to watch Wednesday, March 13 U.S. stocks are little changed early Wednesday, one day after a strong rally sent to the S & P 500 to a new record close. Investors get February's producer price index on Thursday following a slightly hotter-than-expected consumer price index on Tuesday. Eli Lilly teams up with Amazon's pharmacy unit to deliver patients drugs like Zepbound through its LillyDirect service.
TikTok ban legislation hits the House floor on Wednesday. The bill, which is expected to pass, would force the social media platform's Chinese owner ByteDance to sell its U.S. assets or get banned. The prospects in the Senate were still uncertain Tuesday. A ban of TikTok would certainly help Club name Meta Platforms' Reels short-term video feature.shares. The secondary offering was upsized to 14 million shares from the original offering size of 13 million. Frustratingly, GEHC is down 4%.
Morgan Stanley's Adam Jonas upgrades his view on the auto industry to attractive from in-line on the pivot to capital efficiency and return over aggressive spending on EVs and autonomous vehicles. "Auto demand trends strongly support our ICE elongation thesis," Jonas wrote, a thesis that plays into the hand of legacy internal combustion engine makers liketo underweight from equal weight and cuts price target slashed to $125 per share from $200.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients Amazon Pharmacy second online pharmacy to partner with Eli Lilly’s site, and could provide faster deliveries for certain patients.
Lire la suite »
Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug resultsZealand Pharma's Phase 2 trial was an 'uniquivocal win' for a drug that can treat both liver disease and obesity, analysts said.
Lire la suite »
Eli Lilly's Ad Warns Against Misuse of Diabetes and Obesity MedicationsEli Lilly releases a new ad called 'Big Night' to discourage the misuse of prescription medications developed for patients with Type 2 diabetes and obesity. The ad emphasizes that these drugs are not intended for general weight loss purposes and should only be used by those whose health is affected by obesity.
Lire la suite »
Eli Lilly's Alzheimer's drug delayed by FDA: ‘It was unexpected’On Friday, the FDA announced it would postpone a decision on Eli Lilly's potential Alzheimer's treatment donanemab.
Lire la suite »
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Lire la suite »
Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be delayed beyond the end of March as the FDA plans to call a last-minute meeting of its advisers
Lire la suite »